Clinical Trial Update: Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean Section [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing oral misoprostol to intravenous oxytocin for preventing blood loss after non-scheduled cesarean section; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• misoprostol (oral) (misoprostol)
• oxytocin (intravenous) (oxytocin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Postpartum Hemorrhage | Phase 2 | Status: COMPLETED